Psychedelics such as LSD, ketamine and psilocybin, used by therapists to assist in the treatment of certain mental illnesses, could receive billions for state-funded research under a newly proposed bond initiative.
Psychedelics such as LSD, ketamine and psilocybin, used by therapists to assist in the treatment of certain mental illnesses, could receive billions for state-funded research under a newly proposed bond initiative.
Leave A Comment